1. Home
  2. JBI vs SGP Comparison

JBI vs SGP Comparison

Compare JBI & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janus International Group Inc.

JBI

Janus International Group Inc.

HOLD

Current Price

$5.31

Market Cap

728.3M

Sector

Industrials

ML Signal

HOLD

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$20.73

Market Cap

650.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JBI
SGP
Founded
2002
2019
Country
United States
United States
Employees
N/A
65
Industry
Building Products
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
728.3M
650.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
JBI
SGP
Price
$5.31
$20.73
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$9.17
$45.00
AVG Volume (30 Days)
1.2M
170.0K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.36
N/A
Revenue Next Year
$3.16
N/A
P/E Ratio
$12.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.26
$17.06
52 Week High
$10.80
$30.56

Technical Indicators

Market Signals
Indicator
JBI
SGP
Relative Strength Index (RSI) 49.52 52.74
Support Level $4.89 $17.74
Resistance Level $5.50 $22.86
Average True Range (ATR) 0.15 1.74
MACD -0.01 0.07
Stochastic Oscillator 58.47 45.75

Price Performance

Historical Comparison
JBI
SGP

About JBI Janus International Group Inc.

Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. It provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: